Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Clinical Decision Support for Nurses: A Fall Risk and Prevention Example.

Lytle KS, Short NM, Richesson RL, Horvath MM.

Comput Inform Nurs. 2015 Dec;33(12):530-7; quiz E1. doi: 10.1097/CIN.0000000000000192.

PMID:
26571334
2.

Clinical research informatics and electronic health record data.

Richesson RL, Horvath MM, Rusincovitch SA.

Yearb Med Inform. 2014 Aug 15;9:215-23. doi: 10.15265/IY-2014-0009.

3.

Modular design, application architecture, and usage of a self-service model for enterprise data delivery: the Duke Enterprise Data Unified Content Explorer (DEDUCE).

Horvath MM, Rusincovitch SA, Brinson S, Shang HC, Evans S, Ferranti JM.

J Biomed Inform. 2014 Dec;52:231-42. doi: 10.1016/j.jbi.2014.07.006. Epub 2014 Jul 19.

4.

Inactivity of human β,β-carotene-9',10'-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment.

Li B, Vachali PP, Gorusupudi A, Shen Z, Sharifzadeh H, Besch BM, Nelson K, Horvath MM, Frederick JM, Baehr W, Bernstein PS.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10173-8. doi: 10.1073/pnas.1402526111. Epub 2014 Jun 30.

5.

Does access modality matter? Evaluation of validity in reusing clinical care data.

Danford CP, Horvath MM, Hammond WE, Ferranti JM.

AMIA Annu Symp Proc. 2013 Nov 16;2013:278-83. eCollection 2013.

6.

DEDUCE Clinical Text: An Ontology-based Module to Support Self-Service Clinical Notes Exploration and Cohort Development.

Roth C, Rusincovitch SA, Horvath MM, Brinson S, Evans S, Shang HC, Ferranti JM.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:227. eCollection 2013.

PMID:
24303270
7.

Towards the creation of a flexible classification scheme for voluntarily reported transfusion and laboratory safety events.

Whitehurst JM, Schroder J, Leonard D, Horvath MM, Cozart H, Ferranti J.

J Biomed Semantics. 2012 May 18;3:4. doi: 10.1186/2041-1480-3-4.

8.

The design and implementation of an open-source, data-driven cohort recruitment system: the Duke Integrated Subject Cohort and Enrollment Research Network (DISCERN).

Ferranti JM, Gilbert W, McCall J, Shang H, Barros T, Horvath MM.

J Am Med Inform Assoc. 2012 Jun;19(e1):e68-75. Epub 2011 Sep 23.

9.

Using a computerized provider order entry system to meet the unique prescribing needs of children: description of an advanced dosing model.

Ferranti JM, Horvath MM, Jansen J, Schellenberger P, Brown T, DeRienzo CM, Ahmad A.

BMC Med Inform Decis Mak. 2011 Feb 21;11:14. doi: 10.1186/1472-6947-11-14.

10.

The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement.

Horvath MM, Winfield S, Evans S, Slopek S, Shang H, Ferranti J.

J Biomed Inform. 2011 Apr;44(2):266-76. doi: 10.1016/j.jbi.2010.11.008. Epub 2010 Dec 2.

11.

Culture counts--sustainable inpatient computerized surveillance across Duke University Health System.

Cozart H, Horvath MM, Long A, Whitehurst J, Eckstrand J, Ferranti J.

Qual Manag Health Care. 2010 Oct-Dec;19(4):282-91. doi: 10.1097/QMH.0b013e3181fa0680.

PMID:
20924248
12.

Tailoring adverse drug event surveillance to the paediatric inpatient.

Long AL, Horvath MM, Cozart H, Eckstrand J, Whitehurst J, Ferranti J.

Qual Saf Health Care. 2010 Oct;19(5):e40. doi: 10.1136/qshc.2009.032680. Epub 2010 May 28.

13.

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study.

Long AL, Bendz L, Horvath MM, Cozart H, Eckstrand J, Whitehurst J, Ferranti J.

Thromb J. 2010 Feb 18;8:5. doi: 10.1186/1477-9560-8-5.

14.

Sharing adverse drug event data using business intelligence technology.

Horvath MM, Cozart H, Ahmad A, Langman MK, Ferranti J.

J Patient Saf. 2009 Mar;5(1):35-41. doi: 10.1097/PTS.0b013e31819aa951.

PMID:
19920438
15.

Computerized surveillance of opioid-related adverse drug events in perioperative care: a cross-sectional study.

Eckstrand JA, Habib AS, Williamson A, Horvath MM, Gattis KG, Cozart H, Ferranti J.

Patient Saf Surg. 2009 Aug 11;3(1):18. doi: 10.1186/1754-9493-3-18.

16.

Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.

Noureddine MA, Menendez D, Campbell MR, Bandele OJ, Horvath MM, Wang X, Pittman GS, Chorley BN, Resnick MA, Bell DA.

PLoS Genet. 2009 May;5(5):e1000462. doi: 10.1371/journal.pgen.1000462. Epub 2009 May 8.

17.

Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.

Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J.

Pediatrics. 2008 May;121(5):e1201-7. doi: 10.1542/peds.2007-2609.

PMID:
18450863
18.

Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.

Horvath MM, Wang X, Resnick MA, Bell DA.

PLoS Genet. 2007 Jul;3(7):e127. Epub 2007 Jun 15.

19.

Low hanging fruit: a subset of human cSNPs is both highly non-uniform and predictable.

Horvath MM, Fondon JW 3rd, Garner HR.

Gene. 2003 Jul 17;312:197-206. Erratum in: Gene. 2003 Nov 27;320:191.

PMID:
12909356
20.

SNPCEQer: detecting SNPs in sequences generated by the Beckman CEQ2000 DNA Analysis System.

Flood EM, Tang F, Horvath MM, Pertsemlidis A, Garner HR.

Biotechniques. 2002 Oct;33(4):814, 816, 818-20 passim.

21.
22.

Advantage of insulin lispro in suspected insulin allergy.

Pánczél P, Hosszúfalusi N, Horváth MM, Horváth A.

Allergy. 2000 Apr;55(4):409-10. No abstract available.

PMID:
10782533

Supplemental Content

Loading ...
Support Center